Travmaya Organizmanın Metabolik – İmmün – Endokrin Yanıtı

Yazarlar

Enes Şahin

Özet

Organizma, dışarıdan gelen bir travmaya maruz kaldığında homeostasis olarak adlandırılan biyolojik denge halini korumak amacıyla metabolik, immünolojik ve endokrin yanıtlar geliştirir. Travmanın şiddetiyle orantılı olarak salgılanan kortizol, epinefrin ve glukagon gibi hormonlar enerji ihtiyacını karşılamak için hiperglisemi, lipoliz ve proteolizi uyarır; insülin direncini artırır. Hipofiz bezi kontrolündeki CRH, ACTH, tiroid hormonları, büyüme hormonu, prolaktin, endojen opioidler ve AVP de bu süreçte kritik roller üstlenir. Yara iyileşmesi ve enfeksiyonla mücadelede ise sitokinler en güçlü inflamatuar mediatörler olarak işlev görür. TNF-alfa, IL-1, IL-6 gibi proinflamatuar sitokinler ateş, kas yıkımı ve akut faz reaksiyonlarını tetiklerken; IL-4, IL-10 ve IL-13 gibi antiinflamatuar sitokinler bu yanıtı dengeler. Ancak aşırı sitokin üretimi metabolik düzensizliklere ve organ yetmezliğine yol açabilir. Travma sonrası metabolik süreçte, ilk saatlerde azalan metabolizma hızı ve enerji tüketimi yerini doku perfüzyonunun sağlanmasıyla hipermetabolizma, hiperglisemi ve negatif nitrojen dengesine bırakır. Bu katabolik fazda glukoneogenez hızlanır ve glutamin esansiyel bir aminoasit haline gelerek lenfositler ile fibroblastlar için temel enerji kaynağı olur. Lipid metabolizmasında ise trigliseridler harcanan enerjinin büyük kısmını karşılar.

When the organism is exposed to an external trauma, it develops metabolic, immunologic, and endocrine responses to maintain the biological equilibrium known as homeostasis. Hormones such as cortisol, epinephrine, and glucagon, secreted proportionally to the severity of the trauma, stimulate hyperglycemia, lipolysis, and proteolysis to meet energy demands, while increasing insulin resistance. Pituitary-controlled hormones including CRH, ACTH, thyroid hormones, growth hormone, prolactin, endogenous opioids, and AVP also play critical roles in this process. In wound healing and combating infection, cytokines function as the most potent inflammatory mediators. Proinflammatory cytokines like TNF-alpha, IL-1, and IL-6 trigger fever, muscle breakdown, and acute phase reactions, whereas anti-inflammatory cytokines such as IL-4, IL-10, and IL-13 balance this response. However, excessive cytokine production can lead to metabolic disorders and organ failure. In the post-traumatic metabolic process, the initially decreased metabolic rate and energy expenditure are replaced by hypermetabolism, hyperglycemia, and a negative nitrogen balance once tissue perfusion is restored. During this catabolic phase, gluconeogenesis accelerates, and glutamine becomes an essential amino acid, serving as the primary energy source for lymphocytes and fibroblasts. In lipid metabolism, triglycerides meet most of the expended energy.

Referanslar

Lowry, S. F. (2005). Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock, 24, 94-100.

Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFranco, D. B. (2007). Glucocorticoid receptor physiology. Reviews in endocrine and metabolic disorders, 8(4), 321-330.

Flaster, H., Bernhagen, J., Calandra, T., & Bucala, R. (2007). The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Molecular Endocrinology, 21(6), 1267-1280.

Snyder, P. J., & Utıger, R. D. (1972). Response to thyrotropin releasing hormone (TRH) in normal man. The Journal of Clinical Endocrinology & Metabolism, 34(2), 380-385.

Agnese, D. M., Calvano, J. E., Hahm, S. J., Calvano, S. E., & Lowry, S. F. (2002). Insulin-like growth factor binding protein-3 is upregulated in LPS-treated THP-1 cells. Surgical infections, 3(2), 119-126.

Gilbert, K. C., & Brown, N. J. (2010). Aldosterone and inflammation. Current opinion in endocrinology, diabetes, and obesity, 17(3), 199.

Waters, J. P., Pober, J. S., & Bradley, J. R. (2013). Tumour necrosis factor in infectious disease. The Journal of pathology, 230(2), 132-147.

Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood, The Journal of the American Society of Hematology, 117(14), 3720-3732.

Jawa, R. S., Anillo, S., Huntoon, K., Baumann, H., & Kulaylat, M. (2011). Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. Journal of intensive care medicine, 26(2), 73-87.

Scumpia, P. O., & Moldawer, L. L. (2005). Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Critical care medicine, 33(12), S468-S471.

Guirao, X. (2002). Impact of the inflammatory reaction on intermediary metabolism and nutrition status. Nutrition (Burbank, Los Angeles County, Calif.), 18(11-12), 949-952.

Souba, W. W. (1997). Nutritional support. New England Journal of Medicine, 336(1), 41-48.

Shaw, J. H., & Wolfe, R. R. (1989). An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. Annals of surgery, 209(1), 63.

Bistrian, B. R. (2003). Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. Journal of Parenteral and Enteral Nutrition, 27(3), 168-175.

Gelecek

28 Nisan 2022

Lisans

Lisans